Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Dermatological Therapeutics Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Anti-infectives
  • 1.3.3 Corticosteroids
  • 1.3.4 Anti Psoriasis
  • 1.3.5 Anti-acne
  • 1.3.6 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Dermatological Therapeutics Market Share by Application (2019-2025)
  • 1.4.2 Hospital
  • 1.4.3 Clinic
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Dermatological Therapeutics Market Size
  • 2.1.1 Global Dermatological Therapeutics Revenue 2014-2025
  • 2.1.2 Global Dermatological Therapeutics Sales 2014-2025
• 2.2 Dermatological Therapeutics Growth Rate by Regions
  • 2.2.1 Global Dermatological Therapeutics Sales by Regions 2014-2019
  • 2.2.2 Global Dermatological Therapeutics Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Dermatological Therapeutics Sales by Manufacturers
  • 3.1.1 Dermatological Therapeutics Sales by Manufacturers 2014-2019
  • 3.1.2 Dermatological Therapeutics Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Dermatological Therapeutics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Dermatological Therapeutics Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Dermatological Therapeutics Market Concentration Ratio (CR5 and HHI)
• 3.3 Dermatological Therapeutics Price by Manufacturers
• 3.4 Key Manufacturers Dermatological Therapeutics Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Dermatological Therapeutics Market
• 3.6 Key Manufacturers Dermatological Therapeutics Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Anti-infectives Sales and Revenue (2014-2019)
  • 4.1.2 Corticosteroids Sales and Revenue (2014-2019)
  • 4.1.3 Anti Psoriasis Sales and Revenue (2014-2019)
  • 4.1.4 Anti-acne Sales and Revenue (2014-2019)
  • 4.1.5 Others Sales and Revenue (2014-2019)
• 4.2 Global Dermatological Therapeutics Sales Market Share by Type
• 4.3 Global Dermatological Therapeutics Revenue Market Share by Type
• 4.4 Dermatological Therapeutics Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Dermatological Therapeutics Sales by Application

6 United States

• 6.1 United States Dermatological Therapeutics Breakdown Data by Company
• 6.2 United States Dermatological Therapeutics Breakdown Data by Type
• 6.3 United States Dermatological Therapeutics Breakdown Data by Application

7 European Union

• 7.1 European Union Dermatological Therapeutics Breakdown Data by Company
• 7.2 European Union Dermatological Therapeutics Breakdown Data by Type
• 7.3 European Union Dermatological Therapeutics Breakdown Data by Application

8 China

• 8.1 China Dermatological Therapeutics Breakdown Data by Company
• 8.2 China Dermatological Therapeutics Breakdown Data by Type
• 8.3 China Dermatological Therapeutics Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Dermatological Therapeutics Breakdown Data by Company
• 9.2 Rest of World Dermatological Therapeutics Breakdown Data by Type
• 9.3 Rest of World Dermatological Therapeutics Breakdown Data by Application
• 9.4 Rest of World Dermatological Therapeutics Breakdown Data by Countries
  • 9.4.1 Rest of World Dermatological Therapeutics Sales by Countries
  • 9.4.2 Rest of World Dermatological Therapeutics Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 AGI Dermatics
  • 10.1.1 AGI Dermatics Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Dermatological Therapeutics
  • 10.1.4 Dermatological Therapeutics Product Introduction
  • 10.1.5 AGI Dermatics Recent Development
• 10.2 Allergan
  • 10.2.1 Allergan Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Dermatological Therapeutics
  • 10.2.4 Dermatological Therapeutics Product Introduction
  • 10.2.5 Allergan Recent Development
• 10.3 Amgen
  • 10.3.1 Amgen Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Dermatological Therapeutics
  • 10.3.4 Dermatological Therapeutics Product Introduction
  • 10.3.5 Amgen Recent Development
• 10.4 Chester Valley
  • 10.4.1 Chester Valley Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Dermatological Therapeutics
  • 10.4.4 Dermatological Therapeutics Product Introduction
  • 10.4.5 Chester Valley Recent Development
• 10.5 Dermik
  • 10.5.1 Dermik Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Dermatological Therapeutics
  • 10.5.4 Dermatological Therapeutics Product Introduction
  • 10.5.5 Dermik Recent Development
• 10.6 Eisai
  • 10.6.1 Eisai Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Dermatological Therapeutics
  • 10.6.4 Dermatological Therapeutics Product Introduction
  • 10.6.5 Eisai Recent Development
• 10.7 Ferndale
  • 10.7.1 Ferndale Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Dermatological Therapeutics
  • 10.7.4 Dermatological Therapeutics Product Introduction
  • 10.7.5 Ferndale Recent Development
• 10.8 Genentech
  • 10.8.1 Genentech Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Dermatological Therapeutics
  • 10.8.4 Dermatological Therapeutics Product Introduction
  • 10.8.5 Genentech Recent Development
• 10.9 Medicis
  • 10.9.1 Medicis Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Dermatological Therapeutics
  • 10.9.4 Dermatological Therapeutics Product Introduction
  • 10.9.5 Medicis Recent Development
• 10.10 Onset Therapeutics
  • 10.10.1 Onset Therapeutics Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Dermatological Therapeutics
  • 10.10.4 Dermatological Therapeutics Product Introduction
  • 10.10.5 Onset Therapeutics Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Dermatological Therapeutics Sales Channels
  • 11.2.2 Dermatological Therapeutics Distributors
• 11.3 Dermatological Therapeutics Customers

12 Market Forecast

• 12.1 Global Dermatological Therapeutics Sales and Revenue Forecast 2019-2025
• 12.2 Global Dermatological Therapeutics Sales Forecast by Type
• 12.3 Global Dermatological Therapeutics Sales Forecast by Application
• 12.4 Dermatological Therapeutics Forecast by Regions
  • 12.4.1 Global Dermatological Therapeutics Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Dermatological Therapeutics Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Dermatological Therapeutics is 53 million US$ and it will reach 100 million US$ in 2025, growing at a CAGR of 8.7% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dermatological Therapeutics.

This report studies the global market size of Dermatological Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Dermatological Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
AGI Dermatics
Allergan
Amgen
Chester Valley
Dermik
Eisai
Ferndale
Genentech
Medicis
Onset Therapeutics

Market Segment by Product Type
Anti-infectives 
Corticosteroids
Anti Psoriasis
Anti-acne 
Others

Market Segment by Application
Hospital
Clinic

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Dermatological Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Dermatological Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Dermatological Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025